HOSPIRA, INC. for HOSPIRA INC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Termination | Aug 31, 2015 | $270,000 | Replaced |
| 3rd Quarter - Termination Amendment (this page) | Jan 20, 2016 | $180,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIANA REED | — |
Copyright/Patent/Trademark CPT
S. 1137-Protecting American Talent and Entrepreneurship Act of 2015
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIANA REED | — |
Health Issues HCR
Implementation of the Biologics Price Competition and Innovation Act (BPCIA); CMS Proposed Rule {CMS-1631-P} RIN 0938-AS40 - Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2016
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIANA REED | — |
Science/Technology SCI
Issues relating to medical product cybersecurity
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIANA REED | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.